COVID-19 Patient Management in Intensive Care

Objective & Hypothesis:The World Health Organization (WHO) declared the coronavirus outbreak as an international public health emergency (pandemic) on January 31, 2020.

📊

Key Findings & Data:In line with WHO recommendations, in order to guide the Coronaviruse Disease-2019 (COVID-19) agent, transmission routes, case definitions, diagnosis and treatment methods, strategy and application methods, Turkish Ministry of Health, General Directorate of Public Health has prepared guidelines.

💡

Conclusion & Impact:Patients with severe COVID-19 should be treated in the critical care unit.

🔬Design:Research Article

📍Scope:2020 Verileri

⚙️Variables:Domain Parameters

Abstract

The World Health Organization (WHO) declared the coronavirus outbreak as an international public health emergency (pandemic) on January 31, 2020. In line with WHO recommendations, in order to guide the Coronaviruse Disease-2019 (COVID-19) agent, transmission routes, case definitions, diagnosis and treatment methods, strategy and application methods, Turkish Ministry of Health, General Directorate of Public Health has prepared guidelines. Management of patients with COVID‐19 includes epidemiological risk assessment and patient isolation; general and optimized supportive care, symptomatic treatment, respiratory support, nutritional support, psychological intervention etc. for infection prevention and control. The prognosis of patients depends on the severity of the disease, the age of the patient, their underlying diseases and their general medical condition. Patients with severe COVID-19 should be treated in the critical care unit.

🔖

Cite This Article

OKUR, O., MINGIR, T., POLAT, C., TURGUT, N., VATANSEVER, Ş., TEKİN, E. A., GÜLTOP, F., UĞURLU, F. (2022). COVID-19 Patient Management in Intensive Care. European Archives of Medical Research, Cilt: 36 - Sayı: 1, 42–48. https://ajindex.com/articles/510360

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 (SARSCoV-2 Enfeksiyon Rehberi 14.04.2020 Available from: URL: https://www. tjod.org/wp-content/uploads/2020/04/COVID-19_Rehberi-14.04.2020. pdf 2. Liu J, Liu S. The management of coronavirus disease 2019 (COVID‐19). J Med Virol 2020;92:1484-90. 3. Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, et al. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. Ann Acad Med Singap 2020;49:108-18. 4. Wujtewicz M, Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther 2020;52:34- 41. 5. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. 6. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. 7. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. 8. Wilcox SR. Management of respiratory failure due to covid-19. BMJ 2020;369:m1786. 9. Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care 2020;24:154. 10. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults With Coronavirus Disease 2019 (COVID-19) Intensive Care Med 2020;46:854-87. 11. Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 2020;117:10970-5.